1. |
Lortet-Tieulent J, Franceschi S, Dal Maso L, et al. Thyroid cancer “epidemic” also occurs in low- and middle-income countries. Int J Cancer, 2019, 144(9): 2082-2087.
|
2. |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2024, 74(3): 229-263.
|
3. |
Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent, 2024, 4(1): 47-53.
|
4. |
US Preventive Services Task Force; Bibbins-Domingo K, Grossman DC, et al. Screening for thyroid cancer: US Preventive Services Task Force Recommendation Statement. JAMA, 2017, 317(18): 1882-1887.
|
5. |
Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health, 2018, 6(5): e555-e567.
|
6. |
Chen DW, Lang BHH, McLeod DSA, et al. Thyroid cancer. Lancet, 2023, 401(10387): 1531-1544.
|
7. |
常园园, 徐鸿彬, 乔岩, 等. 国外家庭医生签约服务及其对我国的启示. 中国卫生政策研究, 2020, 13(5): 50-53.
|
8. |
刘俊松, 许崇文, 姚小宝, 等. 成人低危型甲状腺微小乳头状癌临床主动监测研究进展. 临床耳鼻咽喉头颈外科杂志, 2023, 37(2): 150-156.
|
9. |
中国抗癌协会甲状腺癌专业委员会. 中国抗癌协会甲状腺癌整合诊治指南 (2022精简版). 中国肿瘤临床, 2023, 50(7): 325-330.
|
10. |
Applewhite MK, James BC, Kaplan SP, et al. Quality of life in thyroid cancer is similar to that of other cancers with worse survival. World J Surg, 2016, 40(3): 551-561.
|
11. |
Aschebrook-Kilfoy B, James B, Nagar S, et al. Risk factors for decreased quality of life in thyroid cancer survivors: initial findings from the North American thyroid cancer survivorship study. Thyroid, 2015, 25(12): 1313-1321.
|
12. |
蔡明, 胡紫宜, 张琨, 等. 甲状腺癌术后患者随访需求调查及影响因素分析. 中国普外基础与临床杂志, 2021, 28(9): 1193-1199.
|
13. |
Husson O, Haak HR, Buffart LM, et al. Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: a study from the population-based PROFILES registry. Acta Oncol, 2013, 52(2): 249-258.
|
14. |
James BC, Aschebrook-Kilfoy B, White MG, et al. Quality of life in thyroid cancer-assessment of physician perceptions. J Surg Res, 2018, 226: 94-99.
|
15. |
Randle RW, Bushman NM, Orne J, et al. Papillary thyroid cancer: the good and bad of the “good cancer”. Thyroid, 2017, 27(7): 902-907.
|
16. |
Banach R, Bartès B, Farnell K, et al. Results of the Thyroid Cancer Alliance international patient/survivor survey: psychosocial/informational support needs, treatment side effects and international differences in care. Hormones (Athens), 2013, 12(3): 428-438.
|
17. |
Morley S, Goldfarb M. Support needs and survivorship concerns of thyroid cancer patients. Thyroid, 2015, 25(6): 649-656.
|
18. |
Hyun YG, Alhashemi A, Fazelzad R, et al. A systematic review of unmet information and psychosocial support needs of adults diagnosed with thyroid cancer. Thyroid, 2016, 26(9): 1239-1250.
|
19. |
刘远丽, 吕婕姝, 刘冰华. 甲状腺癌围术期患者信息需求水平及影响因素分析. 中华现代护理杂志, 2017, 23(19): 2480-2483.
|
20. |
童欣, 杨英, 陈显春. 甲状腺切除术后并发症的护理进展. 当代护士 (下旬刊), 2016, 23(1): 13-15.
|
21. |
蔡明, 苟菊香. 甲状腺癌患者支持性照顾需求与生活质量的纵向调查分析. 中国普外基础与临床杂志, 2022, 29(7): 927-932.
|
22. |
朱晓晖. 甲状腺切除术后并发症的护理进展. 中国医药指南, 2019, 17(36): 9-10.
|
23. |
Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid, 2014, 24(1): 27-34.
|
24. |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016, 26(1): 1-133.
|
25. |
Oda H, Miyauchi A, Ito Y, et al. Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid. Endocr J, 2017, 64(1): 59-64.
|
26. |
Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg, 2010, 34(1): 28-35.
|
27. |
D’Agostino TA, Shuk E, Maloney EK, et al. Treatment decision making in early-stage papillary thyroid cancer. Psychooncology, 2018, 27(1): 61-68.
|
28. |
Zhu P, Zhang Q, Wu Q, et al. Barriers and facilitators to the choice of active surveillance for low-risk papillary thyroid cancer in China: a qualitative study examining patient perspectives. Thyroid, 2023, 33(7): 826-834.
|